← Open Payments lookup

AMMAR ALREFAI: Open Payments

NPI 1720044076 · MADISON, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,263 in 108 payments from 19 companies in 2025. Trend: 2023 $3,084 · 2024 $2,906 · 2025 $2,263

Food & beverage: $2,263
CompanyPaymentsAmount
Alkermes, Inc.16$404
ABBVIE INC.23$325
Neurocrine BioSciences, Inc.12$323
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)13$251
Otsuka America Pharmaceutical, Inc.7$150
Indivior Inc.4$129
Corium, LLC5$108
Takeda Pharmaceuticals U.S.A., Inc.5$98
Teva Pharmaceuticals USA, Inc.4$85
Axsome Therapeutics, Inc.4$65

Products named: ARISTADA, VRAYLAR, INGREZZA, CAPLYTA, REXULTI, SUBLOCADE, Azstarys, TRINTELLIX.

Industry payments across AL — which companies pay providers there.